Which comorbidity risks are decreased following use of continuous positive airway pressure (CPAP) to treat obstructive sleep apnea (OSA)?

Updated: Sep 15, 2020
  • Author: Himanshu Wickramasinghe, MD, MBBS; Chief Editor: Zab Mosenifar, MD, FACP, FCCP  more...
  • Print

A study of 86 patients with sleep apnea, including 75 who had metabolic syndrome, suggests that CPAP is associated with a lower risk for heart disease, stroke, and diabetes. Study participants were treated for 3 months with either CPAP or sham CPAP, followed by a month of no treatment and 3 additional months of the opposite treatment. Of patients treated with CPAP, 13% no longer met diagnostic criteria for metabolic syndrome, compared with 1% of patients in the sham-CPAP control group. CPAP use was also associated with significant weight loss. [163]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!